Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 Next >
Nastech Initiates New Corporate Direction with Name Change to MDRNA, Inc. and Appointment of J. Michael French as Chief Executive Officer
June 10, 2008
from Business Wire News Releases
Nastech Announces Positive Intranasal Insulin Data at American Diabetes Association Meeting
June 09, 2008
- Ultra rapid acting intranasal insulin offers mealtime glucose control with significantly reduced risk of hypoglycemia - Read More
from Business Wire News Releases
Nastech Announces First Quarter 2008 Financial Results
May 08, 2008
from Business Wire News Releases
Nastech to Release First Quarter Financial Results and Host Webcast on Thursday, May 8, 2008
May 01, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. Raises $7.93 Million in Registered Direct Offering
April 25, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. Announces Appointment of Gunter Blobel, M.D., Ph.D., to its MDRNA, Inc. Scientific Advisory Board
March 27, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. to Present RNAi Data
March 25, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350(b)(1)(B)
March 21, 2008
from Business Wire News Releases
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes (As Revised)
March 20, 2008
from PR Newswire
QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes
March 19, 2008
from PR Newswire
Wall Street Media Presents a Video of Dr. Gordon Brandt, President of Nastech Pharmaceutical Company (NASDAQGM: NSTK)
March 18, 2008
from Business Wire News Releases
Nastech Announces Fourth Quarter and Full Year 2007 Financial Results
March 17, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. to Present at the Invest Northwest CEO & Investor Forum
March 13, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. Completes Key RNAi Patent Filings
March 11, 2008
Conference call at 4:15 pm Eastern time (1:15 pm Pacific time) today Read More
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. Announces Scientific Advisory Board for MDRNA, Inc., its Wholly-Owned RNAi Subsidiary
March 07, 2008
from Business Wire News Releases
Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
February 29, 2008
from PR Newswire
Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
February 12, 2008
from PR Newswire
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
February 05, 2008
from PR Newswire
Nastech Completes Enrollment of Phase 2 Clinical Trial of PYY3-36 Nasal Spray to Treat Obesity
January 08, 2008
from PR Newswire
Nastech Receives Notice of Allowance for U.S. Patent Related to Methods for Identifying Cell-Specific Targeting Peptides
January 08, 2008
from PR Newswire
Nastech Appoints Bruce R. York as Interim Chief Financial Officer
January 07, 2008
from PR Newswire
Nastech Announces Promotion of Gordon Brandt, M.D. to President
December 20, 2007
from PR Newswire
Nastech Assigns Intellectual Property Related to the Development of RNA-Based Therapeutics to its Subsidiary, MDRNA, Inc.
December 18, 2007
Assignment of over 100 RNA-related Inventions a Key Step in Establishing MDRNA as an Independent Company Read More
from PR Newswire
Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
December 05, 2007
from PR Newswire
Nastech to Present at BMO Capital Markets Focus on Healthcare Conference
November 27, 2007
from PR Newswire
Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
November 13, 2007
Company to Host Webcast and Conference Call Read More
from PR Newswire
Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
November 13, 2007
from PR Newswire
Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
November 07, 2007
Company Will Advance Product into Phase 2 Bone Mineral Density Study in 1Q08 Read More
from PR Newswire
Nastech to Present at Acumen BioFin Rodman & Renshaw Healthcare Conference
October 31, 2007
from PR Newswire
Nastech Announces Third Quarter 2007 Financial Results
October 29, 2007
from PR Newswire
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here